T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial Twenty-eight patients ...

Despite advances in conventional treatment modalities, patients with metastatic CRC often face limited options and poor outcomes. Chimeric antigen receptor-T (CAR-T) cell therapy, initially successful ...

Universal Chimeric Antigen Receptor-Modified AT19 Cells is under clinical development by Chengdu USino Technology Biology and currently in Phase I for Unspecified B-Cell Lymphomas. According to ...

Introduction: CD7 chimeric antigen receptor T-cell (CAR-T cell) therapy is an emerging method for treating hematological malignancies, and is another breakthrough in CAR-T cell therapy. Methods: This ...

Novel research in cells and mice models has provided insight into the mechanisms that regulate trogocytosis, a process during ...

Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...

Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...

Bristol Myers (BMY) announced the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, has ...